Joshua LaBaer, MD/Ph.D is the Executive Director of the Biodesign Institute and the Director of The Virginia G. Piper Biodesign Center for Personalized Diagnostics (CPD) at Arizona State University. Dr. LaBaer was board certified in internal medicine and medical oncology, which he practiced for 15 years. He served 5 years on the Board of Scientific Advisors for the National Cancer Institute and is a world-renowned proteomics and cancer biomarker researcher. He is President of US-HUPO and co-Chair of Early Detection Research Network and the Breast Cancer Research Foundation. Dr. LaBaer invented the Nucleic Acid Programmable Protein Array (NAPPA) platform that serves as the foundation of the ABAS system. He has extensive research experience in high-throughput functional proteomics, genomics, cellular assays, automation, database/software development, plasmid/virus production as well as gene expression-based mechanistic and modeling studies. He earned his B.S. and M.D./Ph.D. degrees at the University of California, Berkeley, and the University of California, San Francisco, respectively.